Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: New evidence is emerging regarding abnormalities of hypothalamic-pituitary-adrenal (HPA) axis function in subtypes of affective disorders. Adverse effects of HPA axis dysregulation may include dysfunction of monoaminergic transmitter systems, cognitive impairment and peripheral effects. Newer treatments specifically targeting the HPA axis are being developed. OBJECTIVE: To review these developments focusing particularly on the glucocorticoid receptor (GR) antagonist mifepristone. METHOD: A selective review of the literature. RESULTS: The function of GRs is increasingly being defined. The role of corticotrophin-releasing hormone (CRH) and dehydroepiandrosterone (DHEA) in the brain is also increasingly understood. HPA axis function is particularly likely to be abnormal in psychotic depression and bipolar disorder, and it is in these conditions that trials of the GR antagonist mifepristone are being focused. CRH antagonists and DHEA are also being investigated as potential treatments. CONCLUSION: Initial studies of mifepristone and other HPA-axis-targeting agents in psychotic depression and bipolar disorder are encouraging and confirmatory studies are awaited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485 · cited 1×
“(62) found a significantly greater CSF CRH concentration in depressed patients than in healthy volunteers and patients with schizophrenia or dementia.”
BackgroundThe acute effects of corticosteroids on cognition: integration of animal and human model studies
LUPIEN, S., & MCEWEN, B. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00004-0 · Cited by 1,024
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832 · cited 1×
“The volume of the hippocampus is reduced in firstepisode psychosis (104), and there is also evidence of a reduction in volume in this region in the transition from UHR to psychosis (105).”
BackgroundAcute cortisone administration impairs retrieval of long-term declarative memory in humans
de Quervain, D. J.-F., Roozendaal, B., Nitsch, R. M., McGaugh, J. L., & Hock, C. (2000) · Nature Neuroscience · doi:10.1038/73873 · Cited by 745 · cited 1×
“Several studies have reported reduced verbal declarative memory function (127), which may be the result of a specific deficit in memory retrieval (131,132).”
BackgroundZobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Raadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · cited 2×
“CRH is a neurotransmitter with a major role in controlling various aspects of adaptive behaviour [see Holsboer for a review (4)].”
BackgroundVasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636
Lupien, S. J., Gillin, C. J., & Hauger, R. L. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.3.420 · Cited by 561
Decreased memory performance in healthy humans induced by stress-level cortisol treatment
Newcomer, J. W. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.6.527 · Cited by 546 · cited 2×
“Several studies have reported reduced verbal declarative memory function (127), which may be the result of a specific deficit in memory retrieval (131,132).”
BackgroundNeurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519
Self-citationHippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment
Vythilingam, M., Vermetten, E., Anderson, G. M., Luckenbaugh, D., Anderson, E. R., Snow, J., Staib, L. H., Charney, D. S., & Bremner, J. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.002 · Cited by 477
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease
Starkman, M. N., Giordani, B., Gebarski, S. S., Berent, S., Schork, M. A., & Schteingart, D. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00203-6 · Cited by 455 · cited 1×
“(146) used MRI to examine patients with Cushing s disease before and after treatment and found that hippocampal formation volume increased by up to 10% after treatment.”
MethodPurba, J. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020055007 · Cited by 433
Webster, M. J., Knable, M. B., O'Grady, J., Orthmann, J., & Weickert, C. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001139 · Cited by 420
O'Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2081 · Cited by 409 · cited 2×
“(148) carried out neuropsychological assessment, salivary cortisol profiling and MRI in patients older than 60 and in controls at baseline and 6-month follow-up.”
BackgroundThe use of ketoconazole as an inhibitor of steroid production
Oates, J. A., Wood, A. J. J., & Sonino, N. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171307 · Cited by 395 · cited 1×
“These strategies have also tended to be associated with a significant side-effect burden (176), and their efficacy may be compromised by the increased production of other neuroactive steroids.”
BackgroundDST Studies in Psychotic Depression: A Meta-Analysis
Nelson, J. C., & Davis, J. M. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1497 · Cited by 356 · cited 1×
“In contrast, psychotic depression (90) appears to have particularly high rates of DST nonsuppression.”
BackgroundZobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Deuschle, M., Schweiger, U., Weber, B., Gotthardt, U., Körner, A., Schmider, J., Standhardt, H., Lammers, C.-H., & Heuser, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3689 · Cited by 344
De Quervain, D. J. ‐., Henke, K., Aerni, A., Treyer, V., McGaugh, J. L., Berthold, T., Nitsch, R. M., Buck, A., Roozendaal, B., & Hock, C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02542.x · Cited by 342
An open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Young, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318 · cited 1×
“A recent study investigated aGR antagonist in the treatment of bipolar depression, in a double-blind, placebo-controlled crossover design (186).”
BackgroundSelf-citationRapid Reversal of Psychotic Depression Using Mifepristone
Belanoff, J. K., Flores, B. H., Kalezhan, M., Sund, B., & Schatzberg, A. F. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00009 · Cited by 282
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain
Patel, P. D., Lopez, J. F., Lyons, D. M., Burke, S., Wallace, M., & Schatzberg, A. F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00035-2 · Cited by 252 · cited 1×
“High GR concentrations are found in the limbic system and the paraventricular nucleus of the hypothalamus with a preferential distribution in the prefrontal cortex (20).”
BackgroundKRISHNAN, K. R. R., DORAISWAMY, P. M., LURIE, S. N., FIGIEL, G. S., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., & NEMEROFF, C. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-256 · Cited by 232 · cited 1×
“volume of the pituitary gland has been noted in depression compared with healthy subjects (51).”
BackgroundCortisol Circadian Rhythm Alterations in Psychotic Major Depression
Keller, J., Flores, B., Gomez, R. G., Solvason, H. B., Kenna, H., Williams, G. H., & Schatzberg, A. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.014 · Cited by 217
Mineralocorticoid Receptor Function in Major Depression
Young, E. A., Lopez, J. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.24 · Cited by 204 · cited 1×
“There is evidence both of reduced GR function in psychotic and bipolar depression (as discussed above) and of normal or even enhanced MR function in mood disorders (189,190).”
BackgroundPituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790320069009 · Cited by 201
Arousal and cortisol interact in modulating memory consolidation in healthy young men.
Kuhlmann, S., & Wolf, O. T. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.1.217 · Cited by 194
The glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192 · cited 12×
“Indeed, it has been argued that the main abnormality in major depression is in fact a lack of GR-mediated glucocorticoid function in the brain rather than adverse effects associated with high levels of glucocorticoids and mediated by GRs (161).”
BackgroundInfluentialMetyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
Dehydroepiandrosterone treatment of midlife dysthymia∗∗See accompanying Editorial, in this issue.
Bloch, M., Schmidt, P. J., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00066-9 · Cited by 179 · cited 1×
“Two placebo-controlled studies have been conducted in patients aged 45–65 years, and although they have included milder forms of depression not usually associated with HPA axis abnormality, they have shown a significant improvement compared with placebo (178,179).”
BackgroundSchmider, J., Lammers, C.-H., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. E. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00064-x · Cited by 179
Corticosteroid–serotonin interactions in depression: a review of the human evidence
Porter, R. J., Gallagher, P., Watson, S., & Young, A. H. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1774-1 · Cited by 169 · cited 2×
“Likewise, there is little evidence for a direct correlation between 5-HT function and HPA axis function in major depression, although given the variation in phenotype and the difficulties inherent in measuring aspects of each system this is unsurprising (112).”
BackgroundSelf-citationDeBattista, C., Belanoff, J., Glass, S., Khan, A., Horne, R. L., Blasey, C., Carpenter, L. L., & Alva, G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.034 · Cited by 162 · cited 1×
“have published the results of a large randomized controlled trial (RCT) of mifepristone administration in psychotic depression (185).”
BackgroundHolsboer-Trachsler, E., Stohler, R., & Hatzinger, M. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90041-m · Cited by 160
Pariante, C. M., Dazzan, P., Danese, A., Morgan, K. D., Brudaglio, F., Morgan, C., Fearon, P., Orr, K., Hutchinson, G., Pantelis, C., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300766 · Cited by 152
Glucocorticoid Receptor Function In Vitro in Patients with Major Depression
Pariante, C. M. (2004) · Stress · doi:10.1080/10253890500069650 · Cited by 147
Hypothalamic–pituitary–adrenal axis function in patients with chronic depression
WATSON, S., GALLAGHER, P., DEL-ESTAL, D., HEARN, A., FERRIER, I. N., & YOUNG, A. H. (2002) · Psychological Medicine · doi:10.1017/s0033291702005998 · Cited by 130
Self-citationDissociation Between Pituitary and Adrenal Suppression to Dexamethasone in Depression
Young, E. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170073010 · Cited by 71 · cited 1×
“Alterations in the secretion of these POMCproducts andACTHhave been shown indepression (12) andhavebeenused to infer alterations in ACTH levels because of difficulty in measuring ACTH levels.”
BackgroundDose-dependent effects of hydrocortisone on memory in human males
Beckwith, B. E., Petros, T. V., Scaglione, C., & Nelson, J. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90017-x · Cited by 69
Simpson, G. M., Sheshai, A. E., Loza, N., Kingsbury, S. J., Fayek, M., Rady, A., & Fawzy, W. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0509 · Cited by 63
Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., Brewer, W. J., Smith, D. J., Dazzan, P., Berger, G. E., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.018 · Cited by 8
Cited by
Processing of facial emotion expression in major depression: a review
Bourke, C., Douglas, K., & Porter, R. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.496359 · Cited by 557
Self-citationJuruena, M. F., Bocharova, M., Agustini, B., & Young, A. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.052 · Cited by 360
Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268
“Individuals with major depression often have heightened basal cortisol levels (Burke, Davis, Otte, & Mohr, 2005; Porter & Gallagher, 2006), hippocampal-dependent declarative memory impairments (Burt, Zembar, & Niederehe, 1995; Fossati et al., 2004) and encoding deficits (Bremner, Vythilingam,…”
BackgroundNeuropsychological Impairment in Major Depression: Its Nature, Origin and Clinical Significance
Porter, R. J., Bourke, C., & Gallagher, P. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601109881 · Cited by 236
Self-citationAutobiographical memory dysfunctions in depressive disorders
Talarowska, M., Berk, M., Maes, M., & Gałecki, P. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12370 · Cited by 38
“Dysregulation of the HPA axis is found significantly more often in patients with a greater number of episodes and a longer period of disease.(60) The hippocampus is a structure of the brain that is particularly susceptible to stress-induced functional changes and dysregulation of the HPA axis.”
Background
Metadata
- Authors
- Porter, R. J., & Gallagher, P.
- Venue
- Acta Neuropsychiatrica
- Publisher
- Cambridge University Press (CUP)
- Published
- 2006-10
- Volume
- 18
- Issue
- 5
- Pages
- 193-209
- ISSN
- 0924-2708 (ISSN-L)
- 1601-5215
- OpenAlex
- W1990253503
- Cited by
- 45
- References
- 47
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.